Tag: pancreatic cancer
Breakthrough Drug Targeting ‘Undruggable’ KRAS Mutation Nearly Doubles Pancreatic Cancer Survival
New targeted therapy daraxonrasib successfully inhibits KRAS mutations in pancreatic cancer, nearly doubling survival times. Clinical trial shows 60% reduction…
Revolution Medicines Ships Experimental Pancreatic Cancer Drug Under Early Access
Revolution Medicines begins expanded access program for daraxonrasib targeting KRAS G12C mutations. FDA submission planned as five-year pancreatic cancer survival…
Olive Oil Fat Accelerates Pancreatic Cancer While Fish Oil Cuts Risk by Half in Mice
New mouse study reveals oleic acid from olive oil accelerated pancreatic cancer growth while omega-3 fats reduced development by 50%…
Open-Source AI Tool Improves Pancreatic Cancer Vascular Invasion Assessment Across Multiple Centres
New open-source AI system achieves 94.2% accuracy in pancreatic cancer vascular invasion assessment across multiple medical centres. The freely available…
New Drug Daraxonrasib Nearly Doubles Pancreatic Cancer Survival in Phase 3 Trial
Daraxonrasib nearly doubles survival in advanced pancreatic cancer patients with KRAS G12C mutations. The breakthrough targets a previously "undruggable" protein…
New Pancreatic Cancer Drug Daraxonrasib Shows Promise in Phase 2 Trial
A phase 2 trial published in NEJM shows promise for daraxonrasib, a novel targeted therapy for previously treated metastatic pancreatic…
Data-Driven Biomaterials Guide Pancreatic Cancer Cell State Transitions in Lab Models
Researchers develop data-driven biomaterials that control pancreatic cancer cell transitions in organoid models. The breakthrough could reshape tumor biology understanding…